Fløde, Mari
Hermann, Monica
Haugstvedt, Anne
Søfteland, Eirik
Igland, Jannicke
Åsberg, Anders
Jenssen, Trond Geir
Graue, Marit
Article History
Received: 22 April 2023
Accepted: 28 September 2023
First Online: 10 October 2023
Declarations
:
: The study protocol was approved by the Regional Committee for Medical and Health Research Ethics (REK South-East) (2018/512). This research project was conducted in accordance with the Helsinki Declaration. Each participant was completely informed about the study protocol and provided a written and informed consent form before taking part in the study.
: Not applicable.
: Anne Haugstvedt has received lecture fees from Novo Nordisk. Trond Geir Jenssen has received lecture fees from Novo Nordisk, Eli Lilly, Astra Zeneca and Boehringen Ingelheim. Eirik Søfteland has received lecture fees from Novo Nordisk, Boehringen Ingelheim, Astra Zeneca, Otsuko Pharma, Eli Lilly and Sanofi Aventis.Other authors declared no competing interests.